Information intended for UK healthcare professionals only.  These videos have been funded by Galderma UK Ltd and developed in partnership with Guidelines. See bottom of the page for full disclaimer.

View Epiduo 0.1%/2.5% (adapalene and benzoyl peroxide) gel prescribing information
View Epiduo 0.3%/2.5% (adapalene and benzoyl peroxide) gel prescribing information

In these videos Dr Angelika Razzaque (General Practitioner and PCDS Educational Subcommittee Lead), Dr Sangeeta Punjabi (Consultant Dermatologist), and Isabel Lavers (Aesthetics and Specialist Nurse Dermatology) summarise the main messages of the 2021 NICE guideline ’Acne vulgaris: management’.

NICE guideline on the management of acne vulgaris: key messages for primary care

Impact on clinical practice of the NICE guideline on the management of acne vulgaris

Impact on clinical practice of the NICE guideline on the management of acne vulgaris: a nurse perspective

NICE guideline on the management of acne vulgaris: key messages for primary care

Impact on clinical practice of the NICE guideline on the management of acne vulgaris

Impact on clinical practice of the NICE guideline on the management of acne vulgaris: a nurse perspective

Adverse events should be reported. 
For the UK, reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for Yellow Card in the Google Play or Apple App Store.
For Ireland, suspected adverse events can be reported via HPRA Pharmacovigilance, www.hpra.ie;
Adverse events should also be reported to Galderma (UK) Ltd. E-mail: Medinfo.uk@galderma.com Tel: +44 1 923 208950

These videos have been commissioned and funded by Galderma UK Ltd and developed in partnership with Guidelines. Galderma UK Ltd suggested the topic and presenters, and carried out full medical review and approval on all materials to ensure compliance with regulations. The presenters have been paid honoraria. The views and opinions of the presenters are not necessarily those of Guidelines, its publisher, advisers, or advertisers. No part of this video may be reproduced in any form without the permission of the publisher.

UKI-NBD-2100060
Date of preparation: January 2022